Commerzbank Aktiengesellschaft FI bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) in the fourth quarter, Holdings Channel reports. The fund bought 407 shares of the biotechnology company’s stock, valued at approximately $246,000.
A number of other institutional investors and hedge funds have also made changes to their positions in AXON. Groupama Asset Managment bought a new position in shares of Axon Enterprise during the third quarter valued at approximately $200,000. Massachusetts Financial Services Co. MA bought a new position in shares of Axon Enterprise during the third quarter valued at approximately $120,553,000. Proficio Capital Partners LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $78,414,000. Westfield Capital Management Co. LP increased its stake in shares of Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Finally, Assenagon Asset Management S.A. increased its stake in shares of Axon Enterprise by 328.7% during the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after purchasing an additional 111,405 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on AXON shares. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target for the company. in a research report on Thursday, February 20th. Needham & Company LLC reissued a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 26th. Finally, Northland Securities raised their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $587.38.
Insider Transactions at Axon Enterprise
In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the transaction, the director now owns 24,259 shares in the company, valued at $15,518,239.71. This represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,146 shares of company stock worth $3,262,847 in the last 90 days. 6.10% of the stock is currently owned by insiders.
Axon Enterprise Trading Up 1.3 %
NASDAQ:AXON opened at $534.96 on Thursday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The company has a market cap of $40.79 billion, a PE ratio of 138.23, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a 50 day simple moving average of $605.52 and a two-hundred day simple moving average of $527.52.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
- Five stocks we like better than Axon Enterprise
- 3 Tickers Leading a Meme Stock Revival
- Corporate Crawl: Where Business Trips Turn Into Party Nights?
- Best Aerospace Stocks Investing
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- What is a penny stock? A comprehensive guide
- Is Advanced Micro Devices Stock Slide Over?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.